ASXL1 c.1934dup;p.Gly646Trpfs*12-a true somatic alteration requiring a new approach

Blood Cancer J. 2017 Dec 15;7(12):656. doi: 10.1038/s41408-017-0025-8.

Authors

Costas K Yannakou^{1

2}, Kate Jones³, Michelle McBean³, Ella R Thompson^{3

4}, Georgina L Ryland³, Ken Doig³, John Markham^{3

4}, David Westerman^{3

4}, Piers Blombery^{3

4}

Affiliations

¹ Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia. costas.yannakou@petermac.org.
² University of Melbourne, Parkville, VIC, 3010, Australia. costas.yannakou@petermac.org.
³ Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia.
⁴ University of Melbourne, Parkville, VIC, 3010, Australia.

No abstract available

Publication types

Letter

MeSH terms

DNA Mutational Analysis / methods*
Hematologic Neoplasms / genetics*
Humans
Mutation
Repressor Proteins / genetics*

Substances

ASXL1 protein, human
Repressor Proteins